TruDOSE™ began with the vision of founder Tapley Holland. After more than 15 years in the regenerative medicine field, he recognized the shortcomings of the one-size-fits-all model and set out to create a more precise, personalized approach. One night, he envisioned a system that could adapt treatment to each person’s biology. That vision changed everything and led him to leave a comfortable career to build something better.
Elena Herning, now President of TruDOSE™, was once a patient herself. She battled Lyme disease and co-infections for more than 20 years. After finding healing through TruDOSE™, she joined the mission to help others reclaim their lives. Today, she leads national business development and advocates for families who deserve answers.
Together, their journeys shaped more than a company. TruDOSE™ sets a new standard in regenerative care—one that listens, honors every healing story, and empowers people to feel whole again.
Innovator. Builder. Driving Force Behind TruDOSE™.
Tapley Holland has been active in the stem cell and regenerative medicine field since 2005. He developed TruDOSE™ to address the limitations of one-size-fits-all approaches by enabling individualized dosing across a range of disease conditions. Beginning in 2018, his research involving thousands of patients informed precision dosing strategies and supported translational applications across multiple symptoms and disease states. This work contributed to the completion of his PhD in Stem Cell Medicine in February 2026 and to the publication “Platelets as Endogenous Cellular Adaptogens: A Review of Stress Signaling and Regenerative Implications,” which examines the role of platelets in stress response, immune modulation, and regenerative processes. Holland’s work integrates clinical data, mechanistic insights, and translational research to advance precision regenerative therapies for complex neuroimmune and systemic conditions.
Innovator. Builder. Driving Force Behind TruDOSE™.
With more than 15 years in regenerative medicine, Tapley Holland saw firsthand the shortcomings of applying the same treatment to every patient. Determined to change that, he envisioned a system built to deliver the right dose, for the right person, at the right time. That vision changed everything and led him to leave a comfortable career to build TruDOSE™.
Today, Tapley leads with innovation and clarity, creating solutions that give patients and providers new confidence in regenerative care. Under his leadership, TruDOSE™ continues to set a higher standard for personalization, precision, and results.
Survivor. Strategist. Heart of the Mission.
After over 20 years battling Lyme disease and co-infections, Elena experienced life-changing results with TruDOSE™. She joined the company not just as a believer in the science, but as a woman who knew what it meant to be overlooked and misdiagnosed.
Now, Elena leads TruDOSE’s national growth and partnerships with fierce dedication—driven by the families she meets every day who are searching for answers, just like she once was. Her voice reflects thousands. Her leadership shapes the future of personalized healing.